Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune ...
University of Cincinnati reported positive Phase 2 melanoma trial results, with a third of patients responding to a combined ...
The latest update is out from Scancell Holdings ( (GB:SCLP) ).
Melanoma is the most common form of skin cancer, but for patients with advanced melanoma who no longer respond to standard ...
News-Medical.Net on MSN
Breakthrough research offers first targeted treatment option for NRAS-mutant melanoma
New research from Moffitt Cancer Center shows that RAS(ON) multi-selective inhibition can directly block tumor growth and ...
Panelists discuss current frontline therapeutic strategies for advanced melanoma, highlighting the rationale and evolution of ...
Patients with uveal melanoma may respond to T-cell therapy directed at an antigen that is highly expressed in the tumors, ...
Researchers at the UT Austin Portugal Program have developed what they say is a remarkable cancer treatment that combines LED ...
An NHS worker with a deadly cancer is trying to raise £120,000 for life-extending treatment. Jamie Scott has been told she ...
The Healthy @Reader's Digest on MSN
12 Silent Signs of Skin Cancer You’re Probably Ignoring
Subtle signs of skin cancer you shouldn't ignore When the weather gets warmer and daylight hours longer, people are more ...
A Shropshire woman with a deadly cancer has been fundraising for life-extending treatment through bake sales. NHS worker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback